QUANTRO Therapeutics GmbH Alternatives & Competitors
12 companies similar to QUANTRO Therapeutics GmbH — Discovery and development of novel therapeutics targeting transcription factors...
Companies similar to QUANTRO Therapeutics GmbH
Frontier Medicines
Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
Acceleron Pharma
Accelerating drug discovery to transform patients' lives
Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical devel...
Rival Readout
Competing with QUANTRO Therapeutics GmbH? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Promatix Biosciences Ltd
Using multi-omics to develop the next generation of cancer therapeutics
Arvinas
Leading the way in targeted protein degradation therapeutics
Yuanyin Bio
Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clini...
Dicerna Pharmaceuticals
Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference te...
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
Zevra Therapeutics
A Rare Approach to Therapeutics
Magnet Biomedicine
Revolutionizing Human Medicine with Molecular Glues
About QUANTRO Therapeutics GmbH
QUANTRO Therapeutics GmbH, founded in 2019, is a pioneering biotechnology and pharmaceutical company based in Austria. The company is driven by its mission to revolutionize the slogan: "Discovery and development of novel therapeutics targeting transcription factors in cancer and other diseases". The company emerges fro...
Innovative Drug Discovery, Technology Development in Genetics and Transcriptomics, Precision Cell-based Screening
Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Providers, Cancer Treatment Centers
Transcription Factors, Cancer Therapeutics, Drug Discovery, Comparative Transcriptomics, RNA Sequencing, Transcriptional Regulators, Pharmacologic Intervention, IMBA Spin-off, IMP Spin-off, Innovative Drug Pipeline, Disease-Causing Transcriptional Programs, Biopharmaceutical
B2B, B2G
Licensing, Product Sales, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around QUANTRO Therapeutics GmbH: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at QUANTRO Therapeutics GmbH on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.